We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement
MD Anderson Cancer Center Acquires Second Aushon 2470 Microarray Printer for its RPPA Core Facility
Product News

MD Anderson Cancer Center Acquires Second Aushon 2470 Microarray Printer for its RPPA Core Facility

MD Anderson Cancer Center Acquires Second Aushon 2470 Microarray Printer for its RPPA Core Facility
Product News

MD Anderson Cancer Center Acquires Second Aushon 2470 Microarray Printer for its RPPA Core Facility


Want a FREE PDF version of This Product News?

Complete the form below and we will email you a PDF version of "MD Anderson Cancer Center Acquires Second Aushon 2470 Microarray Printer for its RPPA Core Facility"

First Name*
Last Name*
Email Address*
Country*
Company Type*
Job Function*
Would you like to receive further email communication from Technology Networks?

Technology Networks Ltd. needs the contact information you provide to us to contact you about our products and services. You may unsubscribe from these communications at any time. For information on how to unsubscribe, as well as our privacy practices and commitment to protecting your privacy, check out our Privacy Policy

Aushon BioSystems, Inc., has announced that the Department of Systems Biology at the MD Anderson Cancer Center has acquired another 2470 microarray printer from Aushon BioSystems.

The new 2470 Arrayer will be utilized in the Cancer Center Support Grant (CCSG) Functional Proteomics Reverse Phase Protein Array (RPPA) Facility, a core facility that serves all researchers at MD Anderson Cancer Center, as well as other academic institutions and industries.

Extremely high demand for RPPA data and the proven performance of the existing 2470 Arrayer helped drive the acquisition of the additional microarray printer.

Combined with the current 2470 on-site, the ability of the Functional Proteomics RPPA Facility to meet the higher throughput demands for biomarker research and diagnostic testing on cancer patients’ protein pathways and drug reaction will be significantly expanded.

“For each project, we are able to print over 1000 serially diluted samples and 1000 controls on hundreds of slides with our current 2470 microarray printer,” said Gordon Mills, Chairman of the Department of Systems Biology, Chief of the Section of Molecular Therapeutics, and Professor of Medicine and Immunology at the University of Texas MD Anderson Cancer Center.

Mills continued, “This has enabled us to analyze about 200 different proteins and their modifications per project. The CCSG Functional Proteomics RPPA Facility is among the most utilized at MD Anderson, and with the acquisition of our second Aushon 2470, the RPPA core, as well as other RPPA users affiliated with the Department of Systems Biology, will be able to greatly increase the output of RPPA data.”

The Aushon 2470 Arrayer has been installed in leading institutions throughout North America, Europe and Asia to provide rapid, accurate, high-density microarray printing for both genomic and proteomic applications.

It is able to print virtually any sample - including cell lysates and blood - onto substrates with unique shapes and chemistries, as well as a wide range of substrates such as nitrocellulose and silicon chips.

Engineered with walk-away automation, the unique solid pin architecture and proprietary pin design make the 2470 the most flexible and reliable microarray printing platform available.

Advertisement